Matthew Whalen
Patrimonio netto: - $ in data 31/07/2026
Patrimonio netto: - $ in data 31/07/2026
Mr. Matthew P.
Whalen, CPA, is an Independent Director at MIRA Pharmaceuticals, Inc., an Independent Director at Telomir Pharmaceuticals, Inc. and a Chief Financial Officer at Power Digital Marketing, Inc. He is on the Board of Directors at MIRA Pharmaceuticals, Inc. and Telomir Pharmaceuticals, Inc. Mr. Whalen was previously employed as a Chief Financial Officer by MRC Smart Technology Solutions, Inc. He received his undergraduate degree from the University of San Diego.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 21/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 | |
| 21/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 12/08/2024 |
| MIRA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 18/11/2024 |
Power Digital Marketing, Inc.
Power Digital Marketing, Inc. Advertising/Marketing ServicesCommercial Services Operates as a digital marketing agency | Direttore Finanziario/CFO | - |
| Società | Posizione | Fine |
|---|---|---|
MRC Smart Technology Solutions, Inc.
MRC Smart Technology Solutions, Inc. Commercial Printing/FormsCommercial Services Provides printing services | Direttore Finanziario/CFO | 01/05/2021 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
University of San Diego
University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Power Digital Marketing, Inc.
Power Digital Marketing, Inc. Advertising/Marketing ServicesCommercial Services Operates as a digital marketing agency | Commercial Services |
MRC Smart Technology Solutions, Inc.
MRC Smart Technology Solutions, Inc. Commercial Printing/FormsCommercial Services Provides printing services | Commercial Services |
MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale